← Back to Clinical Trials
Recruiting NCT06806618

HAE Burden and Crisis Management

Trial Parameters

Condition Hereditary Angioedema (HAE)
Sponsor University Hospital, Grenoble
Study Type OBSERVATIONAL
Phase N/A
Enrollment 300
Sex ALL
Min Age 12 Years
Max Age N/A
Start Date 2025-03-01
Completion 2025-04-30

Brief Summary

The study has been designed as a French, multicentric survey study to obtain data to describe the burden of on-demand treatment for patients with hereditary angioedema (HAE). The online survey assesses various aspects of HAE and in particular the burden of HAE from the patients' and caregivers' perspectives.

Eligibility Criteria

Inclusion Criteria: For the patient population: 1. Patients with a confirmed diagnosis of HAE with a deficit in the C1 inhibitor. 2. Aged ≥12 years 3. Having consulted for HAE in the last 3 months and with a medical file. For the caregiver population: 1\. A person identified by the patient as part of their support group and who provides support with the management of the patients HAE (including family members, friends, spouse, etc.) Exclusion Criteria: For the patient population: 1. Opposes to participating in the study. 2. Patients is under guardianship or deprived of their liberty.

Related Trials